Keun-Seok Lee

1.0k total citations · 1 hit paper
7 papers, 623 citations indexed

About

Keun-Seok Lee is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Keun-Seok Lee has authored 7 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 2 papers in Cancer Research. Recurrent topics in Keun-Seok Lee's work include HER2/EGFR in Cancer Research (4 papers), Advanced Breast Cancer Therapies (4 papers) and Cancer Treatment and Pharmacology (3 papers). Keun-Seok Lee is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Advanced Breast Cancer Therapies (4 papers) and Cancer Treatment and Pharmacology (3 papers). Keun-Seok Lee collaborates with scholars based in South Korea, China and United States. Keun-Seok Lee's co-authors include Sara A. Hurvitz, Nadia Harbeck, Seock‐Ah Im, Joohyuk Sohn, Marco Colleoni, Yen‐Shen Lu, Aditya Bardia, Debu Tripathy, Tetiana Taran and Arunava Chakravartty and has published in prestigious journals such as New England Journal of Medicine and Journal of Clinical Oncology.

In The Last Decade

Keun-Seok Lee

7 papers receiving 610 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer

2019 591 citations Seock‐Ah Im, Yen‐Shen Lu et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keun-Seok Lee South Korea	4	524	475	233	144	66	7	623
Karen Rodriguez-Lorenc United States	8	655 1.3×	600 1.3×	289 1.2×	179 1.2×	84 1.3×	19	793
Juan Pablo Zarate United States	11	541 1.0×	462 1.0×	255 1.1×	148 1.0×	131 2.0×	29	678
A. Mori Italy	12	729 1.4×	680 1.4×	259 1.1×	213 1.5×	65 1.0×	30	860
T Taran United States	6	561 1.1×	505 1.1×	248 1.1×	113 0.8×	233 3.5×	13	742
HS Rugo United States	13	199 0.4×	459 1.0×	189 0.8×	50 0.3×	105 1.6×	49	561
Farhat Ghaznawi United States	5	245 0.5×	224 0.5×	170 0.7×	83 0.6×	173 2.6×	10	437
Sonya C. Chapman United States	10	363 0.7×	412 0.9×	86 0.4×	128 0.9×	65 1.0×	17	552
Joanne Cox United States	6	525 1.0×	430 0.9×	170 0.7×	214 1.5×	32 0.5×	13	638
Natascha A. J. B. Peters Netherlands	8	310 0.6×	392 0.8×	263 1.1×	27 0.2×	64 1.0×	20	547
Sindy Kim United States	10	575 1.1×	486 1.0×	274 1.2×	143 1.0×	37 0.6×	20	653

Countries citing papers authored by Keun-Seok Lee

Since Specialization

Citations

This map shows the geographic impact of Keun-Seok Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keun-Seok Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keun-Seok Lee more than expected).

Fields of papers citing papers by Keun-Seok Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keun-Seok Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keun-Seok Lee. The network helps show where Keun-Seok Lee may publish in the future.

Co-authorship network of co-authors of Keun-Seok Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Keun-Seok Lee. A scholar is included among the top collaborators of Keun-Seok Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keun-Seok Lee. Keun-Seok Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Lee, Keun-Seok, Xiaojia Wang, Young Hyuck Im, et al.. (2022). Zanidatamab (zani), a HER2-targeted bispecific antibody, in combination with docetaxel as first-line (1L) therapy for patients (pts) with advanced HER2-positive breast cancer: Preliminary results from a phase 1b/2 study.. Journal of Clinical Oncology. 40(16_suppl). 1031–1031. 9 indexed citations

2.

Im, Seock‐Ah, Yen‐Shen Lu, Aditya Bardia, et al.. (2019). Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer. New England Journal of Medicine. 381(4). 307–316. 591 indexed citations breakdown →

3.

Kim, Ji‐Yeon, Eun Jin Lee, Kyunghee Park, et al.. (2018). Role of HER2 copy number amplification and PI3K pathway as a biomarker for patients with HER2+ MBC treating with Poziotinib, pan-HER TKI.. Journal of Clinical Oncology. 36(15_suppl). e13009–e13009. 1 indexed citations

4.

Kim, Ji‐Yeon, Seock‐Ah Im, Kyung Hae Jung, et al.. (2017). A phase II, randomized, open-label 3-arm clinical trial of fulvestrant (F) plus goserelin (G) versus anastrozole (A) plus goserelin (G) versus goserelin (G) alone for hormone receptor (HR) positive, tamoxifen (T) pretreated premenopausal women with recurrent or metastatic breast cance r(MBC) (KCSG BR10-04).. Journal of Clinical Oncology. 35(15_suppl). 1041–1041. 2 indexed citations

5.

Yeo, Winnie, Young‐Hyuck Im, Keun-Seok Lee, et al.. (2015). Safety of eribulin in Korean patients with metastatic breast cancer.. Journal of Clinical Oncology. 33(15_suppl). e12031–e12031. 4 indexed citations

6.

Harbeck, Nadia, Seock‐Ah Im, Chiun‐Sheng Huang, et al.. (2012). LUX-breast 1: Randomized, phase III trial of afatinib and vinorelbine versus trastuzumab and vinorelbine in patients with HER2-overexpressing metastatic breast cancer (MBC) failing one prior trastuzumab treatment.. Journal of Clinical Oncology. 30(15_suppl). TPS649–TPS649. 14 indexed citations

7.

Im, Young‐Hyuck, Winnie Yeo, Kyung Hae Jung, et al.. (2012). A phase III, multicenter, randomized trial of maintenance versus observation after achieving clinical response in patients with metastatic breast cancer who received six cycles of gemcitabine plus paclitaxel as first-line chemotherapy (KCSG-BR 0702, NCT00561119).. Journal of Clinical Oncology. 30(15_suppl). 1003–1003. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact